Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rümke

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Journal of Cancer Research and Clinical Oncology|January 1, 1984
Clinical features of superficial spreading melanomas with zones of regressionB M Czarnetzki, M Denter, E B Bröcker, et al.
Melanoma Research|February 17, 1998
Topical dinitrochlorobenzene combined with systemic dacarbazine in the treatment of recurrent melanomaL J Strobbe, A A Hart, P Rümke, et al.
Cancer Research|July 15, 1989
Potentiation by interleukin 2 of Burkitt's lymphoma therapy with anti-pan B (anti-CD19) monoclonal antibodies in a mouse xenotransplantation modelW M Vuist, F v Buitenen, M A de Rie, et al.
Dermatology (Basel, Switzerland)|January 1, 1996
Prognostic value of tuberculin and BCG immunoreactivity in stage I high-risk malignant melanoma (EORTC protocol 18781)B M Henz, E Macher, E B Bröcker, et al.
The American Journal of Pathology|January 1, 1988
A monoclonal antibody specific for cells of the melanocyte lineageC Vennegoor, P Hageman, H Van Nouhuijs, et al.
The British Journal of Surgery|June 1, 1990
Lymph node metastasis from melanoma with an unknown primary siteA Jonk, B B Kroon, P Rümke, et al.
Cancer|April 1, 1984
Immunohistochemical and histochemical tools in the diagnosis of amelanotic melanomaS G van Duinen, D J Ruiter, P Hageman, et al.
International Journal of Cancer|July 30, 1991
The EORTC Melanoma Group exchange program: evaluation of a multicenter monoclonal antibody studyS Carrel, J F Doré, D J Ruiter, et al.
International Journal of Cancer|October 15, 1986
Characterization of melanoma-associated surface antigens involved in the adhesion and motility of human melanoma cellsJ E de Vries, G D Keizer, A A te Velde, et al.
Melanoma Research|June 1, 1993
Effects of systemic interferon-alpha (IFN-alpha) on the antigenic phenotype of melanoma metastases. EORTC melanoma group cooperative study No. 18852U von Stamm, E B Bröcker, M von Depka Prondzinski, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Journal of Cancer Research and Clinical Oncology|January 1, 1984
Clinical features of superficial spreading melanomas with zones of regressionB M Czarnetzki, M Denter, E B Bröcker, et al.
Melanoma Research|February 17, 1998
Topical dinitrochlorobenzene combined with systemic dacarbazine in the treatment of recurrent melanomaL J Strobbe, A A Hart, P Rümke, et al.
Cancer Research|July 15, 1989
Potentiation by interleukin 2 of Burkitt's lymphoma therapy with anti-pan B (anti-CD19) monoclonal antibodies in a mouse xenotransplantation modelW M Vuist, F v Buitenen, M A de Rie, et al.
Dermatology (Basel, Switzerland)|January 1, 1996
Prognostic value of tuberculin and BCG immunoreactivity in stage I high-risk malignant melanoma (EORTC protocol 18781)B M Henz, E Macher, E B Bröcker, et al.
The American Journal of Pathology|January 1, 1988
A monoclonal antibody specific for cells of the melanocyte lineageC Vennegoor, P Hageman, H Van Nouhuijs, et al.
The British Journal of Surgery|June 1, 1990
Lymph node metastasis from melanoma with an unknown primary siteA Jonk, B B Kroon, P Rümke, et al.
Cancer|April 1, 1984
Immunohistochemical and histochemical tools in the diagnosis of amelanotic melanomaS G van Duinen, D J Ruiter, P Hageman, et al.
International Journal of Cancer|July 30, 1991
The EORTC Melanoma Group exchange program: evaluation of a multicenter monoclonal antibody studyS Carrel, J F Doré, D J Ruiter, et al.
International Journal of Cancer|October 15, 1986
Characterization of melanoma-associated surface antigens involved in the adhesion and motility of human melanoma cellsJ E de Vries, G D Keizer, A A te Velde, et al.
Melanoma Research|June 1, 1993
Effects of systemic interferon-alpha (IFN-alpha) on the antigenic phenotype of melanoma metastases. EORTC melanoma group cooperative study No. 18852U von Stamm, E B Bröcker, M von Depka Prondzinski, et al.
Pageof 5